FDA DEVICE FACTS
SCENARIA View Phase 6.0
Fujifilm Corporation
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The SCENARIA View system is indicated to acquire axial volumes of the whole body including the head. Images can be acquired in axial, helical, or dynamic modes. The SCENARIA View system can also be used for interventional needle guidance. Volume datasets acquired by a SCENARIA View system can be post-processed in the SCENARIA View system to provide additional information. Post-processing capabilities of the SCENARIA View software include multi-planar reconstruction (MPR), and volume rendering. Volume datasets acquired by a SCENARIA View system can be transferred to external devices via a DICOM standard interface. The Low Dose CT Lung Cancer Screening Option for the SCENARIA View system is indicated for using low dose CT for lung cancer screening. The screening must be conducted with the established program criteria and protocols that have been approved and published by a governmental body, a professional medical society, and/or FUJIFILM Corporation. AI/ML algorithms are used for Intelli IPV, AutoPose, AutoPositioning, DLR and Automatic Head Slice Setting. Intelli IPV is developed using machine learning as AI technology to the iterative practical reconstruction automatically. AutoPose is developed using deep learning as AI technology to detect landmarks or regions from a scanogram image. When using AutoPose, be sure to visually check the scan range and adjust it if necessary. AutoPositioning is developed using deep learning as AI technology to detect the patient’s feature points. This function assists in patient positioning operations. Therefore, after completing the positioning operation, be sure to visually check the patient's positioning and the table position by using the light localizer. DLR Focus is developed using deep learning as AI technology to reduce image noise through convolutional processing based on a model obtained by deep learning. Automatic Head Slice Setting is developed using deep learning as AI technology to perform brain region segmentation, brain centroid calculation, and feature point extraction from head volume data. AutoPose, AutoPositioning, DLR Focus and Automatic Head Slice Setting are for adult use only.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。